Product Images Fluzone Quadrivalent Southern Hemisphere

This is a description of Fluzone Quadrivalent, a flu vaccine manufactured by Sanofi Pasteur Inc. The NDC code is listed as 49281-322-88, indicating it is a single-dose injection to be administered intramuscularly. This particular vaccine is intended for use during the Southern Hemisphere's flu season in 2022 and contains no preservatives. The label also includes information about the vaccine's formula (Ry) and location for accessing information about the lot number, expiration date, and 2D database.*

This is a description of a flu vaccine called "Quadrivalent" designed for the Southern Hemisphere. It comes in a 5 mL multi-dose vial that should be stored at 2° to 8°C (35° to 46°F) and should not be frozen. The vaccine is meant for intramuscular injections only, and it contains preservatives. The formula was created in 2022 and is manufactured by Sanofi Pasteur Inc. The US Govt License #1725 is included. The full prescribing information is available for detailed information.*

This is a description of the Fluzone Quadrivalent influenza vaccine for the 2022 season. The vaccine contains standardized hemagglutinin representative of prototype strains for H1N1, H3N2, and two B-lineages. It comes in a 5 mL multi-dose vial and must be stored between 2° and 8°C. The vaccine is prepared from influenza viruses propagated in embryonated chicken eggs and inactivated with formaldehyde. It is for intramuscular injection only and contains thimerosal as a preservative. The age range for administration is 6 months and older. Shake well before use. Full prescribing information is available. Not-made with natural rubber latex.*